Stryker Corporation Stock Intrinsic Value – Stryker Expands Global Footprint with Acquisition of SERF SAS

☀️Trending News

Stryker Corporation ($NYSE:SYK), a leading medical technology company, has announced its plans to acquire SERF SAS, a France-based joint replacement company. This acquisition will expand Stryker’s already impressive global footprint and increase their presence in the orthopaedic market. Stryker Corporation is a leading medical technology company that guides the transformation of healthcare by providing innovative solutions in the areas of orthopaedics, medical and surgical, and neurotechnology and spine. By continually focusing on customer needs and potential market opportunities, Stryker has grown to become one of the most successful and respected medical technology companies in the world. This acquisition of SERF SAS is another strategic move by Stryker that will undoubtedly expand their global reach and enhance their product offering in the orthopaedic market.

With SERF SAS’s expertise in joint replacement solutions, this acquisition allows Stryker to expand its portfolio of orthopaedic products and offer a comprehensive suite of solutions for customers in the medical industry. The acquisition of SERF SAS is the latest move by Stryker Corporation to strengthen its portfolio and increase its presence in the medical technology space. This strategic move will undoubtedly pay off for the company in the long run as they continue to have a positive impact on the lives of their customers and the global healthcare system.

Price History

On Monday, STRYKER CORPORATION, a leading medical technology company, announced the acquisition of France-based SERF SAS in order to expand its global footprint. This acquisition is expected to strengthen Stryker’s industry-leading presence in Europe and beyond. STRYKER CORPORATION stock opened at $291.4 on Monday and closed at $291.5, up by 0.5% from its last closing price of 290.2. The acquisition will enable Stryker to build on its already strong portfolio of innovative medical technologies, acquire new products, expand into new markets, and increase its global presence.

With the acquisition of SERF SAS, Stryker will be able to leverage the expertise of the company’s leadership team and their deep knowledge of the European market to gain a competitive edge. Overall, the acquisition of SERF SAS is expected to provide Stryker with new growth opportunities and help strengthen its position as a leader in medical technology. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Stryker Corporation. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Stryker Corporation. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Stryker Corporation. More…

Key Ratios Snapshot

Some of the financial key ratios for Stryker Corporation are shown below. More…

Analysis – Stryker Corporation Stock Intrinsic Value

At GoodWhale, we have conducted a financial analysis of STRYKER CORPORATION. Through our proprietary Valuation Line, we have determined that the intrinsic value of STRYKER CORPORATION’s share is around $284.9. Currently, STRYKER CORPORATION’s stock is trading at $291.5, which is a fair price but slightly overvalued by 2.3%. More…

Peers

Stryker Corporation is one of the world’s largest medical technology companies. It offers a broad range of products including orthopedic implants, surgical instruments, medical equipment and software solutions. The company operates in over 100 countries and has a strong presence in the United States, Europe and Asia. Stryker’s competitors include Fukuda Denshi Co Ltd, Nihon Kohden Corp and Shanghai Sanyou Medical Co Ltd.

– Fukuda Denshi Co Ltd ($TSE:6960)

Fukuda Denshi Co. Ltd., together with its subsidiaries, manufactures and sells medical electronic equipment in Japan and internationally. The company operates through five segments: Diagnostic Cardiology, Diagnostic Imaging, Patient Monitoring, Electrotherapy, and Others. It offers diagnostic cardiology products, including electrocardiographs, stress test systems, Holter systems, ambulatory blood pressure monitors, and medical printers; and diagnostic imaging products comprising X-ray diagnostic systems, computed tomography systems, magnetic resonance imaging systems, ultrasound diagnostic systems, X-ray angiography systems, and nuclear medicine diagnostic systems. The company also provides patient monitoring products, such as central station systems, telemetry systems, patient monitors, and related accessories; electrotherapy products, such as shortwave diathermy machines and physical therapy equipment; and other products, such as endoscopic and ophthalmologic equipment. It sells its products primarily to general hospitals, clinics, and other health care facilities. The company was founded in 1930 and is headquartered in Tokyo, Japan.

– Nihon Kohden Corp ($TSE:6849)

Nihon Kohden Corp. is a Japanese manufacturer of medical equipment, headquartered in Tokyo. The company was founded in 1952 and has since grown to become a leading supplier of medical equipment in Japan. Nihon Kohden’s product lineup includes everything from patient monitors and electrocardiographs to ultrasound machines and medical robotics. The company also offers a wide range of services, including maintenance and repair services for its products.

Nihon Kohden has a market capitalization of 269.63 billion as of 2022. The company’s return on equity is 11.49%. Nihon Kohden is a leading manufacturer of medical equipment in Japan. The company offers a wide range of products and services, including maintenance and repair services for its products.

– Shanghai Sanyou Medical Co Ltd ($SHSE:688085)

Shanghai Sanyou Medical Co Ltd is a medical company with a market cap of 6.32B as of 2022. The company’s return on equity is 8.85%. Shanghai Sanyou Medical Co Ltd is engaged in the research, development, manufacture, and sale of medical devices and equipment. The company’s products include medical imaging equipment, medical consumables, and medical disposables.

Summary

Stryker Corporation is a medical technology company that designs, manufactures, and markets medical devices, specialty surgical instruments, and medical equipment. The company has recently announced plans to acquire France-based joint replacement company SERF SAS. The move is expected to expand Stryker’s portfolio of hip and knee implants and provide them with a strong presence in Europe.

Analysts believe the acquisition could bring attractive growth opportunities to Stryker in the form of increased market share, revenue growth, and cost savings. Investors should watch for updates on this acquisition as it could provide a positive boost to Stryker’s stock.